memo & hrc

Tel : +44 (0)1382 383119
Email: fast-study@memo.dundee.ac.uk

The FAST study (Febuxostat versus Allopurinol Streamlined Trial)

The FAST study is a major research project designed to assess the safety of drugs commonly used to treat gout in general practice in Scotland, England and Denmark. The study commenced in 2011 and is expected to run until at least 2015.

About FAST


Gout is a metabolic disorder characterised by sudden and very severe attacks of pain, swelling and inflammation in the joints of the feet, knees, ankles, hands and wrists – and especially in the big toes. It has become the commonest type of inflammatory arthritis, affecting 1-2% of all people seen by doctors ...

more info...

How FAST works


Patients with gout who have already been prescribed allopurinol are being invited to take part in the FAST study. The nurses in the FAST team arrange to see potential participants at their GP’s surgery or other suitable location to explain the study in more detail. The nurses check that there are no reasons why ...

more info...

For more information about what MEMO hopes to achieve, visit www.dundee.ac.uk/memo, or to read more on some of MEMOs other trials, click on the trial images below...